Rochal Industries, established in 1986, is a global leader in commercializing technology innovations in natural and synthetic polymers, antimicrobials, and biological systems. As a research-oriented company focused on wound and skin care, Rochal created the field of non-stinging liquid bandages in the 1990’s. The company’s current pipeline contains transformative products for mitigation of opportunistic pathogens and biofilm, wound re-epithelialization and closure, necrotic tissue debridement, cell compatible substrates and transdermal drug delivery. Rochal drives its pipeline from concept to preclinical and clinical development while meeting quality and regulatory requirements.
In 2014, The Catalyst Group, Inc., a middle market private equity firm with offices in Houston and Austin, Texas, partnered with Rochal to help grow and commercialize their innovative products. Catalyst currently has ownership interests in several companies in the healthcare industry including Sanara MedTech Inc, who has an exclusive licence to market, sell, distribute, and further develop three impactful Rochal products: BIAKŌS™ Antimicrobial Skin and Wound Cleanser, BIAKŌS™ Antimicrobial Barrier Film and No Sting Skin Protectant.
Rochal Industries, LLC Leadership
Rebecca McMahon, Ph.D., MBA
Rebecca McMahon, Ph.D., MBA is the president of Rochal Industries. Dr. McMahon has held a variety of research and development positions since joining Rochal in 2015. Prior to Rochal, Dr. McMahon was a Postdoctoral Fellow at MD Anderson Cancer Center in Houston. Rebecca received a Ph.D. in Chemical Engineering from Texas A&M, an MBA from UTSA, and a dual BS degree in Chemical Engineering and Science, Technology, and Society from Rensselaer Polytechnic Institute.
Ann Beal Salamone, MA
Ann Beal Salamone, Chairman of the Board, has led six science-based companies from concept to commercial financial success. She is a member of the National Academy of Engineering and one of the principal inventors of Rochal Industries' wound care products. During her career, she has created polymer chemistry-based products within the flexible circuit, integrated chip, personal care, and healthcare industries. Mrs. Salamone is a past Chairman of the American Chemical Society Division of Polymer Chemistry (8,000 member organization) and currently serves on the board of Sanara MedTech and BioMed SA. She is a recipient of the Crystal Slipper Award "Executive Woman of the Year."